399 related articles for article (PubMed ID: 18234297)
1. Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy.
Richard SD; Krivak TC; Castleberry A; Beriwal S; Kelley JL; Edwards RP; Sukumvanich P
Gynecol Oncol; 2008 Apr; 109(1):43-8. PubMed ID: 18234297
[TBL] [Abstract][Full Text] [Related]
2. Role of wide/radical hysterectomy and pelvic lymph node dissection in endometrial cancer with cervical involvement.
Mariani A; Webb MJ; Keeney GL; Calori G; Podratz KC
Gynecol Oncol; 2001 Oct; 83(1):72-80. PubMed ID: 11585416
[TBL] [Abstract][Full Text] [Related]
3. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
5. The abandoned radical hysterectomy: a Gynecologic Oncology Group Study.
Whitney CW; Stehman FB
Gynecol Oncol; 2000 Dec; 79(3):350-6. PubMed ID: 11104604
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
8. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
Havrilesky LJ; Leath CA; Huh W; Calingaert B; Bentley RC; Soper JT; Alvarez Secord A
Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
[TBL] [Abstract][Full Text] [Related]
9. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy.
Schorge JO; Molpus KL; Koelliker D; Nikrui N; Goodman A; Fuller AF
Gynecol Oncol; 1997 Jul; 66(1):31-5. PubMed ID: 9234917
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study.
Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF
Cancer; 1999 Nov; 86(10):2059-65. PubMed ID: 10570432
[TBL] [Abstract][Full Text] [Related]
12. A comparison of laparoscopic radical hysterectomy and pelvic lymphadenectomy and laparotomy in the treatment of Ib-IIa cervical cancer.
Li G; Yan X; Shang H; Wang G; Chen L; Han Y
Gynecol Oncol; 2007 Apr; 105(1):176-80. PubMed ID: 17197013
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study.
Sedlis A; Bundy BN; Rotman MZ; Lentz SS; Muderspach LI; Zaino RJ
Gynecol Oncol; 1999 May; 73(2):177-83. PubMed ID: 10329031
[TBL] [Abstract][Full Text] [Related]
14. A comparison of laparascopic-assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical cancer.
Steed H; Rosen B; Murphy J; Laframboise S; De Petrillo D; Covens A
Gynecol Oncol; 2004 Jun; 93(3):588-93. PubMed ID: 15196849
[TBL] [Abstract][Full Text] [Related]
15. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
Elliott KS; Borowsky ME; Malka ES; Scudder SA; Leiserowitz GS; Russell AH
J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
[TBL] [Abstract][Full Text] [Related]
17. Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
Diaz JP; Sonoda Y; Leitao MM; Zivanovic O; Brown CL; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2008 Nov; 111(2):255-60. PubMed ID: 18755500
[TBL] [Abstract][Full Text] [Related]
18. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
[TBL] [Abstract][Full Text] [Related]
19. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
20. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer.
Pieterse QD; Kenter GG; Gaarenstroom KN; Peters AA; Willems SM; Fleuren GJ; Trimbos JB
Eur J Surg Oncol; 2007 Mar; 33(2):216-21. PubMed ID: 17097845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
